Regenerative V LiftTM Facelift
The Regenerative V LiftTM Facelift is a trademarked next-generation facial rejuvenation procedure that restores youthful contours through a vertical vector lift while enhancing the body’s regenerative power for superior healing time and natural-looking results. This advanced technique combines precise surgical repositioning of facial tissues with targeted biologic therapies delivered at every stage of the patient’s journey.
What is Exosome Therapy?
Exosomes are naturally occurring tiny extracellular vesicles released by cells that carry signaling molecules (proteins, lipids, and genetic material) involved in cell-to-cell communication. Exosomes are applied in aesthetic settings due to their potential role in supporting skin repair, reducing inflammation, and promoting collagen production. Exosomes can be derived from Wharton’s Jelly (a gelatinous substance from umbilical cord tissue rich in mesenchymal stem cells and bioactive factors) or adipose-derived stem cells (ADSCs) found it fat tissue.
What is Stem Cell Therapy?
Stem cells are undifferentiated cells capable of self-renewal and differentiation into various cell types. Allogeneic stem cells are donated by healthy volunteer donors—such as from umbilical cord tissue (Wharton’s Jelly) collected after birth or from adult donors—and are carefully screened, processed, and banked for use in other patients under strict regulatory guidelines. Stem cells may be used intraoperatively to support tissue integration and healing. Wharton’s Jelly-derived mesenchymal stem cell products in particular are being explored in regenerative aesthetics research for their high concentration of growth factors and anti-inflammatory properties.
What is Hyperbaric Oxygen Therapy (HBOT)?
A perioperative HBOT protocol delivers high-concentration oxygen in a pressurized chamber to enhance tissue oxygenation, which may accelerate wound healing and reduce recovery time.
FDA Note
Exosome products and allogenic stem cells materials are regulated by the FDA as biological products. There are currently no FDA-approved exosome products or allogeneic stem cell products for injection or aesthetic use. These supportive therapies are offered as part of an individualized treatment plan and may be used in accordance with applicable regulations, physician discretion, and patient informed consent. Results vary and are not guaranteed. Please consult with our surgeon for a full discussion of options, risks, and regulatory considerations.
Regenerative Healing Surgical Package
Dr. Marisa Viñas understands the importance of incorporating regenerative techniques in order to provide optimal post-operative healing. Therefore, all surgical therapies with Dr. Viñas have the opportunity to be enhanced with regenerative medicine in the form of peri-operative exosomes and intra-operative stem cell therapy. Dr. Viñas is also partnered with local hyperbaric oxygen therapy centers with an established protocol for her patients. Further information can be provided upon surgical consultation.